A ranar 27 ga Afrilu, 2022, Gwajin Innovita 2019-nCoV Ag ya sami Amincewar TGA.
Lambar shaida: DV-2021-MC-25164-1
Har zuwa yanzu, Innovita covid-19 gwajin antigen don amfani da ƙwararru da amfani da gwajin kai sun sami takardar shedar EU CE, Ostiraliya TGA takaddun shaida, da cancantar shiga kasuwa na Jamus, Faransa, Netherlands, Hungary, Brazil, Argentina, Philippines, Thailand , Saudi Arabia, Brunei, da dai sauransu.
Lokacin aikawa: Afrilu-28-2022